USA-based health technology company committed to bringing accessible health monitoring to everyone, Sonde Health raised USD 19.25 million in Series B. The round took place on December 9, 2022. Partners Investment led the financing for the firm. Meanwhile, NEOM Company and KT Corporation joined in the funding. Besides, existing investors, including co-founder PureTech Health and M Ventures, participated in the financing.
So far, the total funding raised by the firm stands at USD 35.25 million. As a part of the deal, Vice President of Partners Investment, Joonsoo Kim, intends to join Sonde Health’s board of directors.
Purpose of financing for Sonde Health
With the latest financing from the Series B round, the company aims to drive its global commercial growth. It also seeks to deepen its respiratory and mental health monitoring technologies.
Besides, it has plans to build capabilities for additional health conditions.
What the co-founder has to say
David Liu, CEO of Sonde Health, said, “Digital biomarkers are becoming a mainstay in healthcare. Today’s healthcare companies realize how vocal biomarkers can engage people earlier in their health. The data and insights found in voice can power health monitoring and patient stratification so issues can become apparent well before a costly medical event occurs. With voice and any listening device, accessible and effective health monitoring can be made available to the majority of the world.”
What the investor has to say
Vice President of Partners Investment, Joonsoo Kim, said, “Sonde is at the forefront of a vocal biomarker revolution that has the potential to change how we detect, manage, and understand our health. They have the deepest, high-quality dataset combined with leading edge-processing technology, which gives them a significant competitive advantage. We believe Sonde’s team and platform are primed to disrupt and add tremendous value to health monitoring around the world, and we’re thrilled to support the company’s mission to harness the power of voice for better health.”
About the company
In 2015 Founders Jim Harper, Jon Z Lin, and Michael C. Chen launched Sonde Health. Sonde is a leader in voice-based health monitoring. The company works with top health companies, providers, pharma, and device OEMs through its vocal biomarker platform. Sonde has the largest and most diverse health-labelled voice dataset, with more than 1.2 million voice samples from over 85,000 subjects on four continents. Sonde provides its enterprise vocal biomarker technology to companies across several health verticals, including telehealth, pharmaceutical, remote patient monitoring, and consumer/medical devices.
For more extensive analysis and Market Intelligence reports, feel free to approach us.
We try our best to fact-check and bring well-researched as well as non-plagiarized content to you. Please let us know
if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover
–what information you are looking for, in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!
Next Article
